Impulse Dynamics
A cardiac medical device company determined to improve the lives of heart failure patients through CCM® therapy
A cardiac medical device company determined to improve the lives of heart failure patients through CCM® therapy
Impulse Dynamics is a biotechnology company based in the United States, founded in 1996. The company is focused on enhancing the lives of individuals with heart failure through its innovative Optimizer®CCM® therapy delivery system. This breakthrough treatment aims to improve the quality of life for heart failure patients by enhancing heart contractions to facilitate better oxygenation of the body. The therapy, known as CCM®, offers a safe and minimally invasive option for millions of patients who lack effective treatment alternatives. Notably, Impulse Dynamics received a significant $136.00M Venture Round investment from Redmile Group, Perceptive Advisors, Hobart Healthcare, and Alger on 14th February 2024. The company's commitment to addressing the unmet needs of heart failure patients, combined with the support of prominent investors, positions Impulse Dynamics as a noteworthy player in the cardiac medical device sector. For more information, visit the company's website.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $136.00M | 4 |
|
14 Feb 2024 |
| Debt Financing | Unknown | - | 12 May 2022 | |
| Venture Round | $101.00M | 5 |
|
12 May 2022 |
| Venture Round | $91.39M | - | 24 Feb 2022 | |
| Series D | $60.00M | 3 |
|
12 Jan 2021 |
No recent news or press coverage available for Impulse Dynamics.
We care about your data, and we'd love to use cookies make your experience better.
